Mostrar el registro sencillo del ítem

dc.contributor.authorRubín García, María
dc.contributor.authorJiménez Moleón, José Juan 
dc.date.accessioned2021-01-18T10:21:09Z
dc.date.available2021-01-18T10:21:09Z
dc.date.issued2020-10-26
dc.identifier.citationRubín-García, M., Vitelli-Storelli, F., Molina, A. J., Zamora-Ros, R., Aragonés, N., Adarnaz, E., ... & Martín, V. (2020). Association between Polyphenol Intake and Gastric Cancer Risk by Anatomic and Histologic Subtypes: MCC-Spain. Nutrients, 12(11), 3281. [doi:10.3390/nu12113281]es_ES
dc.identifier.urihttp://hdl.handle.net/10481/65493
dc.description.abstractSeveral anticancer properties have been largely attributed to phenolics in in vivo and in vitro studies, but epidemiologic evidence is still scarce. Furthermore, some classes have not been studied in relation to gastric cancer (GC). The aim of this study was to assess the relationship between the intake of phenolic acids, stilbenes, and other phenolics and the risk of developing GC and its anatomical and histological subtypes. We used data from a multi-case-control study (MCC-Spain) obtained from di erent regions of Spain. We included 2700 controls and 329 GC cases. Odds ratios (ORs) were calculated using mixed e ects logistic regression considering quartiles of phenolic intake. Our results showed an inverse association between stilbene and lignan intake and GC risk (ORQ4 vs. Q1 = 0.47; 95% CI: 0.32–0.69 and ORQ4 vs. Q1 = 0.53; 95% CI: 0.36–0.77, respectively). We found no overall association between total phenolic acid and other polyphenol class intake and GC risk. However, hydroxybenzaldehydes (ORQ4 vs. Q1 = 0.41; 95% CI: 0.28–0.61), hydroxycoumarins (ORQ4 vs. Q1 = 0.49; 95% CI: 0.34–0.71), and tyrosols (ORQ4 vs. Q1 = 0.56; 95% CI: 0.39–0.80) were inversely associated with GC risk. No di erences were found in the analysis by anatomical or histological subtypes. In conclusion, a diet high in stilbenes, lignans, hydroxybenzaldehydes, hydroxycoumarins, and tyrosols was associated with a lower GC risk. Further prospective studies are needed to confirm our results.es_ES
dc.description.sponsorshipInstituto de Salud Carlos IIIes_ES
dc.description.sponsorshipInstituto de Salud Carlos III European Union (EU) PI08/1770 PI08/0533 PI08/1359 PS09/00773-Cantabria PS09/01286-Leon PS09/01903-Valencia PS09/02078-Huelva PS09/01662-Granada PI11/01403 PI11/01889-FEDER PI11/00226 PI11/01810 PI11/02213 PI12/00488es_ES
dc.description.sponsorshipInstituto de Salud Carlos III API 10/09es_ES
dc.description.sponsorshipICGC International Cancer Genome Consortium CLL (Spanish Ministerio de Economia y Competitividad (MINECO) through the Instituto de Salud Carlos III (ISCIII))es_ES
dc.description.sponsorshipICGC International Cancer Genome Consortium CLL (Spanish Ministerio de Economia y Competitividad (MINECO) through Red Tematica de Investigacion del Cancer (RTICC) del ISCIII) RD12/0036/0036es_ES
dc.description.sponsorshipJunta de Castilla y León LE22A10-2es_ES
dc.description.sponsorshipJunta de Andalucía PI-0571-200 PI-0306-2011 salud201200057018traes_ES
dc.description.sponsorshipConselleria de Sanitat of the Generalitat Valenciana AP_061/10es_ES
dc.description.sponsorshipLa Caixa Foundation 2010ACUP 00310es_ES
dc.description.sponsorshipRegional Government of the Basque Countryes_ES
dc.description.sponsorshipConsejería de Sanidad de la Región de Murciaes_ES
dc.description.sponsorshipEuropean Commission European Commission Joint Research Centre FOOD-CT-2006-036224-HIWATEes_ES
dc.description.sponsorshipSpanish Association Against Cancer (AECC) Scientific Foundationes_ES
dc.description.sponsorshipCatalan Government Agency for Management of University and Research Grants (AGAUR) grants 2017SGR723 2014SGR850es_ES
dc.description.sponsorshipFundación Caja de Ahorros de Asturiases_ES
dc.description.sponsorshipUniversity of Oviedoes_ES
dc.description.sponsorship"Miguel Servet" program from the Institute of Health Carlos III (European Social Fund (ESF)-ESF investing in your future) CP15/00100es_ES
dc.description.sponsorshipMinistry of Education of Spain FPU17/06488es_ES
dc.description.sponsorshipUniversity of Leones_ES
dc.description.sponsorshipSpanish Ministry of Science and Innovation through the "Centro de Excelencia Severo Ochoa 2019-2023" Program CEX2018-000806-Ses_ES
dc.description.sponsorshipGeneralitat de Catalunya through the CERCA Programes_ES
dc.description.sponsorshipThe Instituto de Salud Carlos III-FEDER PI12/00265 PI12/01270 PI12/00715 PI12/00150 PI14/01219 PI14/0613 PI15/00069 PI15/00914 PI15/01032 PI17CIII/00034es_ES
dc.language.isoenges_ES
dc.publisherMdpies_ES
dc.rightsAtribución 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectDiet es_ES
dc.subjectEpidemiology es_ES
dc.subjectGastric canceres_ES
dc.subjectPolyphenolses_ES
dc.subjectPhenolic acidses_ES
dc.subjectStilbeneses_ES
dc.subjectLignanses_ES
dc.subjectAnatomices_ES
dc.subjectHistologices_ES
dc.subjectMCC-Spaines_ES
dc.titleAssociation between Polyphenol Intake and Gastric Cancer Risk by Anatomic and Histologic Subtypes: MCC-Spaines_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/nu12113281
dc.type.hasVersionVoRes_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 3.0 España
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 3.0 España